Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CCR3 | P51677 | 1/20 | 0.33 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29201756 | 0.91 | KMT2A (0.37) | MGLLTSHRKMT2AHSD11B1POLB | |
| SCHEMBL31677350 | 0.90 | TSHR (0.35) | MGLLTSHRHSD11B1SMYD3LIPG | |
| SCHEMBL30864109 | 0.88 | GPR119 (0.40) | KMT2A | |
| SCHEMBL31697885 | 0.88 | MGLL (0.39) | MGLLTSHRHSD11B1CCR3 | |
| SCHEMBL27123888 | 0.88 | MGLL (0.39) | MGLLTSHRHSD11B1CCR3 | |
| SCHEMBL30872307 | 0.86 | MGLL (0.35) | MGLLTSHRHSD11B1CCR3SMYD3 | |
| SCHEMBL31677318 | 0.85 | SMYD3 (0.34) | TSHRKMT2ASMYD3 | |
| SCHEMBL30014221 | 0.84 | ITGB3 (0.38) | MGLLTSHRHSD11B1CCR3 | |
| SCHEMBL27125679 | 0.84 | ITGB3 (0.38) | MGLLTSHRHSD11B1CCR3 | |
| SCHEMBL29201746 | 0.83 | MGLL (0.39) | MGLLTSHRHSD11B1CCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4606803-A1 | KRAS G12D DEGRADATION AGENT, AND PREPARATION METHOD AND USE THEREFOR | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (CN) | 2025-08-27 | — | — | EP | disclosed |